secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vericel Corp (VCEL)
CIK:        0000887359
Form:       8-K
Filed at:   2026-07-30T12:03:54+00:00
Accession:  0001628280-26-050815
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vericel Q2 revenue up 22% to $77.5M, raises FY guidance, authorizes $200M buyback
--------------------------------------------------------------------------------

- Q2 total revenue $77.5M (+22% YoY); MACI $65.5M (+23%); Burn Care $12.0M (+22%).
- Net income $2.2M ($0.04 diluted EPS) vs net loss $0.6M in Q2 2025; adjusted EBITDA margin 19%.
- FY 2026 revenue guidance raised to $330-340M (from $326-336M); MACI to $284-290M; Burn Care to $46-50M.
- Board authorized $200M share repurchase program; company has $227M cash and no debt.
- Free cash flow $14.3M in Q2; record MACI biopsies and implants; UK MHRA submission for MACI.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/887359/000162828026050815/0001628280-26-050815-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/887359/000162828026050815/vcel-20260730.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-050815

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer